Methylxanthine derivative that improves blood flow by decreasing blood viscosity. Identity as a metabolite of pentifylline, q.v.: Mohler et al., Arch. Pharm. 299, 448 (1966); Mohler et al., Arzneim.-Forsch. 16, 1524 (1966). Prepn: NL 6511581; Mohler et al., DE 1235320; eidem, US 3422107 (1966, 1967, 1969 all to Chem. Werke Albert). Series of articles on chemistry, pharmacology and clinical trials: Arzneim.-Forsch. 21, 1159-1177 (1971). Toxicity data: K. Popendiker et al., ibid. 1160. Review of hemorheologic properties and use in cerebrovascular disease: R. Müller, F. Lehrach, Curr. Med. Res. Opin. 7, 253-263 (1981); of pharmacology and therapeutic uses: A. Ward, S. P. Clissold, Drugs 34, 50-97 (1987); C. P. Samlaska, E. A. Winfield, J. Am. Acad. Dermatol. 30, 603-621 (1994).
Hemorheologic agent.
Hemorheologic Agent